Additionally, tracking lab test results, such as tumor markers, imaging scans, or blood counts, can provide valuable information on cancer progression and response to treatment. Monitoring medications, including chemotherapy, immunotherapy, or radiation therapy, can ensure adherence to the prescribed treatment plan. Regularly documenting doctor visits, procedures, and their outcomes can also help individuals track their treatment progress, communicate effectively with their healthcare team, and make informed decisions about their cancer care.
Sample health journal entries that can be entered into Goopatient*:
Date: July 28, 2023
To manage #fatigue, I will ensure adequate rest and incorporate light physical activities as tolerated. I plan to eat small, frequent meals to improve my #appetite and will discuss my nausea with my oncologist during the upcoming visit.
To manage #fatigue, I will ensure adequate rest and incorporate light physical activities as tolerated. I plan to eat small, frequent meals to improve my #appetite and will discuss my nausea with my oncologist during the upcoming visit.
Today, I experienced mild fatigue and intermittent abdominal pain following my #chemotherapy session yesterday. I also noticed a slight loss of appetite and felt nauseous in the morning.
It is possible that the recent #chemotherapy treatment might have contributed to my fatigue and #abdominal_discomfort. The stress related to an upcoming important event might have contributed to my loss of appetite and nausea.
I took my prescribed anti-nausea medication #Ondansetron 8mg this morning to alleviate my symptoms.
I measured my body #temperature and found it to be within the normal range 36,9.
I have an upcoming follow-up appointment with my oncologist #Dr.Brown next week to discuss my symptoms and overall treatment progress.
You can also add to your health journal encourading news about advances in the cancer management. Here are some of them:
CRISPR pioneer Jennifer Doudna's startup is creating a one-shot cancer vaccine.
Azalea Therapeutics, a biotech company co-founded by Nobel laureate and CRISPR co-creator Jennifer Doudna, has raised $82 million to develop a revolutionary cancer therapy - a single injection that reprograms a patient's T cells directly within the body. The technology combines virus-like particles (EDVs) for precise delivery of the CRISPR editor and adeno-associated viruses, which allow genes to be inserted into precisely defined sections of DNA. The combination of these technologies enables a single injection that modifies T cells while preserving their natural behavior. Azalea has already conducted experiments in mice and research in primates is underway. The company is also exploring the possibility of applying the technology to hematopoietic stem cells and B cells. Azalea stands out from its competitors thanks to its unique ability to precisely program gene placement in T cells. This could potentially lead to the development of safe and effective drugs.